Blood News and Research

RSS

Scientists develop novel treatment strategy for multiple myeloma

Scientists at Virginia Commonwealth University Massey Cancer Center have developed a novel treatment strategy for multiple myeloma that pairs two targeted agents to kill cancer cells. The study's findings, published in today's edition of the journal "Blood," are the first to demonstrate the synergistic, anti-myeloma effects of this combination regimen both in vitro and in vivo.

11 Feb 2011

Promedior initiates Phase 1b clinical study of PRM-151 in patients with IPF

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today that it has initiated a Phase 1b clinical study of PRM-151 to explore the safety, tolerability, pharmacokinetics, and phamacodynamics of PRM-151 in the treatment of patients with idiopathic pulmonary fibrosis.

11 Feb 2011

New findings of drug recently identified to prevent stroke in patients with AF published in NEJM

New findings from a McMaster University-led study of a drug recently identified to prevent stroke in patients with atrial fibrillation have been published in the high-impact New England Journal of Medicine today.

11 Feb 2011

Patients with high blood pressure have benign endocrine tumours in adrenal gland: Research

High blood pressure may in some cases be caused by benign hormone-producing tumours of the adrenal cortex. A joint Swedish-American research effort has now uncovered a genetic cause behind the occurrence of such tumours. The findings were published today in the journal Science.

11 Feb 2011

Valeant Pharmaceuticals subsidiary acquires Canadian rights to Cholestagel

Valeant Pharmaceuticals International, Inc. today announced that its subsidiary, Biovail Laboratories International SRL, has acquired the Canadian rights to Cholestagel (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, from Genzyme Corporation.

10 Feb 2011

Regular exercise improves ability of overweight children to think, do math: Researchers

Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.

10 Feb 2011

Cytomedix granted CE mark for Angel Blood Separation System and activAT Autologous Thrombin Processing Kit

Cytomedix, Inc. today announced that the Company has been issued a CE marking certification for its Angel® Whole Blood Separation System ("Angel") and its activAT® Autologous Thrombin Processing Kit ("activAT").

10 Feb 2011

TGMC installs third Toshiba Infinix DP-i system with Next Generation Advanced Image Processing

As a nationally recognized healthcare organization, home to one of the most advanced vascular interventional practices in the country, Terrebonne General Medical Center (TGMC) handles approximately 3,300 cath lab patients annually. Patients from all over the country come to TGMC for interventional treatment for conditions associated with cardiovascular disease (CVD) and peripheral vascular disease (PVD), including limb ischemia.

10 Feb 2011

Women with high folic acid levels may impact child's risk of developing asthma

Recent Norwegian research suggests that there may be a connection between high levels of folic acid in pregnant mothers and the development of asthma in their children. However, the researchers stress that pregnant women should continue to take folic acid supplements.

10 Feb 2011

Alexion fourth quarter net product sales of Soliris increases to $156.0 million

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2010. For the three months ended December 31, 2010, Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $156.0 million, reflecting strong additions of new patients, compared to $110.6 million for the same period in 2009.

10 Feb 2011

Key advance in development of fast, simple test for detection of cholera

With cholera on the rampage in Haiti and almost 40 other countries, scientists are reporting the development of a key advance that could provide a fast, simple test to detect the toxin that causes the disease. The report appears in ACS' journal Bioconjugate Chemistry. Cholera affects more than 200,000 people annually, mainly in developing countries, and causes about 5,000 deaths. Many involve infants, children, and the elderly.

10 Feb 2011

Lakewood Regional Medical Center supports 'Focus on the Heart' campaign

With approximately one death occurring every 36 seconds from cardiovascular disease, Americans need to find a way to beat the odds. That premise is the impetus behind Lakewood Regional Medical Center's new campaign, which encourages the community to "Focus on the Heart" by undergoing regular screenings and adopting a heart-healthy lifestyle.

10 Feb 2011

DNA sequencing of maternal blood plasma can accurately detect trisomy 21

In a study published online today in the American Journal of Obstetrics & Gynecology, researchers from the Sequenom Center for Molecular Medicine confirmed that DNA sequencing of maternal blood plasma could accurately detect trisomy 21.

10 Feb 2011

Afinitor plus BSC doubles progression-free survival in patients with advanced pancreatic neuroendocrine tumors

The New England Journal of Medicine (NEJM) published a study today that shows Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival (PFS), or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET).

10 Feb 2011

Scientists develop novel approach to detect long-distance chromosomal interactions for CAD

The discovery that a "gene desert" on chromosome 9 was a hotspot for coronary artery disease (CAD) risk was among the highlights of findings produced recently by genome-wide association studies, which compare the genomes of many people for genetic variations and have been broadly used in the past few years to study hundreds of diseases and complex traits. Gene deserts are large genomic segments devoid of genes.

10 Feb 2011

Luciferase enzyme offers promise for improved monitoring of heparin therapy: New study

The enzyme that makes fireflies glow is lighting up the scientific path toward a long-sought new medical imaging agent to better monitor treatment with heparin, the blood thinner that millions of people take to prevent or treat blood clots, scientists are reporting. Their study appears in the ACS' monthly journal Bioconjugate Chemistry.

10 Feb 2011

UCSD: Medication education can help patients with diabetes better stick to drug treatment plans

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego say that medication education is a key factor in helping patients with diabetes better stick to their drug treatments plans.

10 Feb 2011

First patient treated in cytomegalovirus~ACE/ASPECT Phase II randomised clinical trial

Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces today that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London.

10 Feb 2011

Georgia Tech, Emory University startup receives $5.1M investment to develop novel cardiac surgery system

A Georgia Tech and Emory University medical device startup that has developed a system to simplify and standardize the technique for opening and closing the beating heart during cardiac surgery has received a $5.1 million investment.

10 Feb 2011

ALQAEM to release online blood glucose monitor in the M.E.N.A. regions

The Health Care Division of ALQAEM International FZE, the exclusive master distributor for the M.E.N.A. region of the UFIT noninvasive medical device created by Biosign Technologies Inc. of Canada, is pleased to announce that it has placed orders for delivery this quarter and will begin a limited release in March to those M.E.N.A. regions that recognize the CE Mark for medical device registration.

10 Feb 2011

Blood News and Research

Scientists develop novel treatment strategy for multiple myeloma

Promedior initiates Phase 1b clinical study of PRM-151 in patients with IPF

New findings of drug recently identified to prevent stroke in patients with AF published in NEJM

Patients with high blood pressure have benign endocrine tumours in adrenal gland: Research

Valeant Pharmaceuticals subsidiary acquires Canadian rights to Cholestagel

Regular exercise improves ability of overweight children to think, do math: Researchers

Cytomedix granted CE mark for Angel Blood Separation System and activAT Autologous Thrombin Processing Kit

TGMC installs third Toshiba Infinix DP-i system with Next Generation Advanced Image Processing

Women with high folic acid levels may impact child's risk of developing asthma

Alexion fourth quarter net product sales of Soliris increases to $156.0 million

Key advance in development of fast, simple test for detection of cholera

Lakewood Regional Medical Center supports 'Focus on the Heart' campaign

DNA sequencing of maternal blood plasma can accurately detect trisomy 21

Afinitor plus BSC doubles progression-free survival in patients with advanced pancreatic neuroendocrine tumors

Scientists develop novel approach to detect long-distance chromosomal interactions for CAD

Luciferase enzyme offers promise for improved monitoring of heparin therapy: New study

UCSD: Medication education can help patients with diabetes better stick to drug treatment plans

First patient treated in cytomegalovirus~ACE/ASPECT Phase II randomised clinical trial

Georgia Tech, Emory University startup receives $5.1M investment to develop novel cardiac surgery system

ALQAEM to release online blood glucose monitor in the M.E.N.A. regions

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News